Back to list

Sub-theme 09: Lessons from the life sciences: Examining pharmaceuticals, biotechnology and beyond

Convenors:
Fiona Murray, Massachusetts Institute of Technology, Boston, USA
fmurray@mit.edu
Walter W. Powell, Stanford University, California, USA
woodyp@stanford.edu
M. Lourdes Sosa, London Business School, London, UK
l.sosa@lse.ac.uk
Session I: Thursday, July 02, 09:00 to 10:30, E3-0-0014
Comparative Studies of National Systems
Chair: Fiona Murray, Lourdes Sosa, Woody Powell
Breaking the Ivory Tower:
Search mechanisms in forming founding teams: a comparative study of British and Dutch biotechnology start ups
The age of industrial science and the gentleman scholar: the rise of biotechnology
Discussant: Fiona Murray
Session II: Thursday, July 02, 11:00 to 12:30, E3-0-0014
Governance, Organizational Design and Innovation
Chair: Fiona Murray, Lourdes Sosa, Woody Powell
Nils Ferrand, Christopher Wasden and Richard Manning
Accelerating biopharma innovation through market discipline: an agent-based model of the pharmaceutical complex adaptive system
Anna S Nilsson and Annika Rickne
Collaborative Structures in Early-Stage Biotech Research Commercialization
How Do Firms "Use" Users? Collaborative innovation in the medical device industry
Lourdes Sosa
High-Risk Radical Innovation and the Role of De Novo Firms in Creative Destruction

Discussants: Carolin Haeussler and Woody Powell
Session III: Thursday, July 02, 14:00 to 15:30, E3-0-0014
Governance and Alternative Models of Organizing in Biotechnology
Chair: Fiona Murray, Lourdes Sosa, Woody Powell
Eva Passarge
Against a World Model for Radical Innovations? The Orchestration of Swiss Biotechnology by Pharmaceutical Companies
The 'rationalized entrepreneur' model. Conclusions from the German entrepreneurship dynamic in biotechnology
Michael M. Hopkins, Rocio Alvarez-Tinoco, Paul Nightingale and Charles Baden-Fuller
Servants in drug discovery and development: A neglected organizational form for biotech firms
Discussant: Aaron Chatterji
Session IV: Friday, July 03, 09:00 to 10:30, E3-0-0014
Microfoundations in Life Sciences R&D
Chair: Fiona Murray, Lourdes Sosa, Woody Powell
Is it really worth it? PhD students and supervisors principles for evaluating doctoral studies in the life sciences.
Creativity in Interdisciplinary Networks
Collaborative Benefits and Coordination Costs: Learning and Capability Development in Science
Discussant: Jeannette Colyvas
Session V: Friday, July 03, 11:00 to 12:30, E3-0-0014
Comparative Studies of Academic vs. Industrial Systems
Chair: Fiona Murray, Lourdes Sosa, Woody Powell
The determinants of information sharing: An analysis of firm and university scientists in the bio-sciences
VALUE CREATION IN UNIVERSITY-FIRM RESEARCH COLLABORATIONS
Andrew Nelson
How Does Scientific Know-How Diffuse Across Organizations? Longitudinal Diffusion Mechanisms and the Varying Roles of Personal Ties
Discussant: Michael Hopkins
Session VI: Saturday, July 04, 09:00 to 10:30, E3-0-0014
Industrial and Regional Clusters
Chair: Fiona Murray, Lourdes Sosa, Woody Powell
Zeynep Erden, Georg von Krogh, Cecilia Nytorp and Marcus Hultberg
Strategic Groups in the Biopharmaceutical Industry: Implications for Performance
Sophie Dalziel, Michael Meeks, Rebecca Bednarek and Christine Ross
Towards a High Performance Bioeconomy: Determining Cluster Priorities and Capabilities in New Zealand
Clustering dynamics in high technologies: a comparison between biotechnologies, medical imaging, signal processing, & nanoelectronics.
Woody Powell
Organizational and Institutional Genesis

Discussants: Andrew Nelson and Simcha Jong
Session VII: Saturday, July 04, 11:00 to 12:30, E3-0-0014
Formal and Informal Institutional Systems in the Life Sciences
Chair: Fiona Murray, Lourdes Sosa, Woody Powell
The supply side of the global health: An analysis of the procurement of ARVs, the organisation of access to treatment, and therapeutic markets in Uganda.
The innovative cancer treatment research market: its emergence and evolution
The Collective Creation of new Social Technologies - Institutional entrepreneurship in China’s biopharmaceutical sector
Discussant: Lourdes Sosa

Wrap-up